ArticleFrontiers in microbiology2026
Isolation and characterization of novel microorganisms producing natural compounds of possible industrial interest: an integrated genomic and metabolomic approach.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigates the discovery of bioactive natural compound (BNC)-producing microorganisms from diverse, marine and terrestrial extreme environments using an integrated genomic and metabolomic approach. BNCs, including pigments, antimicrobials, and antioxidants, play pivotal roles in microbial adaptation and constitute valuable resources for applications spanning pharmaceuticals to sustainable materials. To enhance the likelihood of isolating BMC producers, a pigmentation-guided strategy was applied across three ecologically distinct and extreme environments: alpine glacier snow, volcanic marine sediments, and marine holobionts exposed to natural CO Results: This approach yielded 51 pigmented microbial isolates, encompassing both bacteria and fungi across multiple phyla. From this collection, seven representative strains exhibiting high growth rate and consistent and intense pigmentation were selected for in-depth characterization. Whole-genome sequencing and biosynthetic gene cluster (BGC) analysis revealed extensive biosynthetic potential, with 61 BGCs identified, including pathways associated with terpenes, polyketide synthases (PKS), and non-ribosomal peptide synthetases (NRPS). Complementary metabolomic profiling via UPLC-QTOF-MS confirmed the production of a broad spectrum of BNC, with 58 natural products being detected, including carotenoids, antimicrobial compounds, biosurfactants, and polyketide-derived pigments. Functional assays further demonstrated the ability of these strains to metabolize amylaceous substrates and plant-derived carbohydrates, highlighting their suitability for sustainable biotechnological processes based on renewable feedstocks. Notably, two isolates affiliated with Conclusion: Overall, this work underscores the effectiveness of coupling pigmentation-based screening with omics-driven analyses to uncover microorganisms as candidate cell factory for BNC production. The identified strains represent promising candidates for sustainable biotechnological applications, including the production of natural pigments, antimicrobials, and bio-based materials, thereby contributing to the advancement of circular and eco-friendly industrial systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.